![Calvin Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Calvin Yu worked as Senior Director-Finance & SEC Reporting at Adverum Biotechnologies, Inc. from 2014 to 2016.
Prior to that, he worked as Controller at Five Prime Therapeutics, Inc. from 2010 to 2014.
He also worked as Controller at Stemcentrx, Inc. from 2016 to 2017.
Currently, he is the Chief Financial & Accounting Officer at Alector, Inc. Mr. Yu completed his undergraduate degree from San Francisco State University.
Antiguos cargos conocidos de Calvin Yu.
| Empresas | Cargo | Fin |
|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Comptroller/Controller/Auditor | 01/06/2017 |
| ADVERUM BIOTECHNOLOGIES, INC. | Director Financiero/CFO | 01/02/2016 |
| FIVE PRIME THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/09/2014 |
| ALECTOR, INC. | Director Financiero/CFO | 08/09/2021 |
Formación de Calvin Yu.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
17
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
- Bolsa de valores
- Insiders
- Calvin Yu
